Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Eledon Pharmaceuticals (ELDN) Cash from Investing Activities (2016 - 2017)

Historic Cash from Investing Activities for Eledon Pharmaceuticals (ELDN) over the last 5 years, with Q2 2017 value amounting to $18.9 million.

  • Eledon Pharmaceuticals' Cash from Investing Activities rose 27037142.86% to $18.9 million in Q2 2017 from the same period last year, while for Sep 2017 it was $23.3 million, marking a year-over-year increase of 719481.71%. This contributed to the annual value of -$70.3 million for FY2024, which is 5526.31% down from last year.
  • Latest data reveals that Eledon Pharmaceuticals reported Cash from Investing Activities of $18.9 million as of Q2 2017, which was up 27037142.86% from $4.3 million recorded in Q1 2017.
  • Eledon Pharmaceuticals' 5-year Cash from Investing Activities high stood at $18.9 million for Q2 2017, and its period low was -$24.3 million during Q2 2015.
  • In the last 5 years, Eledon Pharmaceuticals' Cash from Investing Activities had a median value of -$9000.0 in 2014 and averaged -$1.2 million.
  • Per our database at Business Quant, Eledon Pharmaceuticals' Cash from Investing Activities plummeted by 40481666.67% in 2015 and then soared by 27037142.86% in 2017.
  • Quarter analysis of 5 years shows Eledon Pharmaceuticals' Cash from Investing Activities stood at -$4000.0 in 2013, then plummeted by 3825.0% to -$157000.0 in 2014, then crashed by 101.27% to -$316000.0 in 2015, then soared by 104.11% to $13000.0 in 2016, then surged by 145538.46% to $18.9 million in 2017.
  • Its Cash from Investing Activities was $18.9 million in Q2 2017, compared to $4.3 million in Q1 2017 and $13000.0 in Q4 2016.